
pmc: PMC7836116
handle: 2263/79329
AbstractSARS-CoV-2 501Y.V2 (B.1.351), a novel lineage of coronavirus causing COVID-19, contains substitutions in two immunodominant domains of the spike protein. Here, we show that pseudovirus expressing 501Y.V2 spike protein completely escapes three classes of therapeutically relevant antibodies. This pseudovirus also exhibits substantial to complete escape from neutralization, but not binding, by convalescent plasma. These data highlight the prospect of reinfection with antigenically distinct variants and foreshadows reduced efficacy of spike-based vaccines.
COVID-19 Vaccines, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 pandemic, COVID-19, Blood Donors, Antibodies, Viral, Article, Coronavirus disease 2019 (COVID-19), Neutralization Tests, Spike Glycoprotein, Coronavirus, Infectious diseases, Humans, Immune Evasion
COVID-19 Vaccines, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 pandemic, COVID-19, Blood Donors, Antibodies, Viral, Article, Coronavirus disease 2019 (COVID-19), Neutralization Tests, Spike Glycoprotein, Coronavirus, Infectious diseases, Humans, Immune Evasion
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1K | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.01% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 0.1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.01% |
